The global infusion therapy devices market size will grow by USD 2.32 billion during 2019-2023. The report provides a detailed analysis of the market by product (accessories and consumables and pumps), infusion type (continuous infusion, intermittent infusion, infusion-on-demand, and total parenteral infusion), and geography (Asia, Europe, North America, and ROW). The report analyzes the market’s competitive landscape and offers information on several infusion therapy device manufacturers including B. Braun Melsungen AG, Becton Dickinson and Co., F. Hoffmann-La Roche Ltd., Fresenius Kabi AG, ICU Medical Inc., Medtronic, and Terumo Corp.

To identify growth opportunities. the infusion therapy devices market has been segmented into regions that are growing faster than the overall market. These regions have been pitted against regions that have a slower growth rate than the global market in 2018-2023. Asia and North America will grow faster than the overall market. The market growth of Europe and ROW will be slower than the global market.

Some of the key findings from our infusion therapy market forecast report are summarized below

Infusion Therapy Devices Market

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from the report.

Get a FREE sample now!
Global infusion therapy devices industry overview

The growing prevalence of chronic diseases such as cancer is driving the need for home-based treatment. This is increasing the demand for medical devices such as infusion therapy devices that facilitate safe, accurate and precise drug delivery based on the patient’s requirement. Moreover, the wireless and remote programming capabilities in homecare infusion pumps allow physicians and pharmacists to regulate the medication dosage parameters, which helps in reducing hospital visits. Because of such benefits, there is a growing demand for these devices in home care settings, which will subsequently drive the growth of the global infusion therapy devices market.

Smart infusion therapy devices help eliminate errors caused by incorrect administration of medication. These devices can be programmed and managed by the hospital pharmacy department with inputs from the pharmacy and the therapeutics committee. Advancements have also led to the development of wireless smart therapy devices which can be remotely monitored. These wireless smart therapy devices enable bi-directional communication between the server and the pump. This facilitates the remote transfer of hospital-specific drug libraries as well as other configuration parameters to pumps. The emergence of such smart infusion therapy devices is one of the key trends that will drive infusion therapy devices market growth at a CAGR of about 6% during 2019-2023.
https://www.technavio.com/report/global-infusion-therapy-devices-market-industry-analysis?utm_source=off-page&utm_medium=blog&utm_campaign=2020-ch-W15